Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys: 923 trades; $2B in total
Open-market sales: 1,038 trades; $2.3B in total
Insiders filing: 464 insiders; Last 7 days
Companies with several buyers: 26; Last 7 days

		Trade type
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/25–06/26	06/29	32,876 sh2 trades	$8.89avg.	$292,126.48	+0.2%
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/25–06/26	06/29	32,876 sh2 trades	$8.89avg.	$292,126.48	+0.2%
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/25–06/26	06/29	32,876 sh2 trades	$8.89avg.	$292,126.48	+0.2%
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/25–06/26	06/29	32,876 sh2 trades	$8.89avg.	$292,126.48	+0.2%
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/25–06/26	06/29	32,876 sh2 trades	$8.89avg.	$292,126.48	+0.2%
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/25–06/26	06/29	32,876 sh2 trades	$8.89avg.	$292,126.48	+0.2%
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/12–06/16	06/16	531,326 sh3 trades	$8.66avg.	$4,599,903.46	+3.3%
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/12–06/16	06/16	531,326 sh3 trades	$8.66avg.	$4,599,903.46	+3.3%
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/12–06/16	06/16	531,326 sh3 trades	$8.66avg.	$4,599,903.46	+3.3%
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/12–06/16	06/16	531,326 sh3 trades	$8.66avg.	$4,599,903.46	+3.3%
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/12–06/16	06/16	531,326 sh3 trades	$8.66avg.	$4,599,903.46	+3.3%
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/12–06/16	06/16	531,326 sh3 trades	$8.66avg.	$4,599,903.46	+3.3%
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/09–06/11	06/11	1,027,722 sh3 trades	$7.44avg.	$7,650,148.29	+6.8%
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/09–06/11	06/11	1,027,722 sh3 trades	$7.44avg.	$7,650,148.29	+6.8%
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/09–06/11	06/11	1,027,722 sh3 trades	$7.44avg.	$7,650,148.29	+6.8%
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/09–06/11	06/11	1,027,722 sh3 trades	$7.44avg.	$7,650,148.29	+6.8%
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/09–06/11	06/11	1,027,722 sh3 trades	$7.44avg.	$7,650,148.29	+6.8%
Director	Artiva BiotherapeuticsARTV	Open-market buy	06/09–06/11	06/11	1,027,722 sh3 trades	$7.44avg.	$7,650,148.29	+6.8%
10% Owner	Artiva BiotherapeuticsARTV	Open-market buy	05/11	05/28	1,432,291 sh2 trades	$11.52avg.	$16,499,992.32	No record
10% Owner	Artiva BiotherapeuticsARTV	Open-market buy	05/11	05/28	1,432,291 sh2 trades	$11.52avg.	$16,499,992.32	No record